EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma

Ling Yan, Huidong Hu, Lei Feng, Zhe Li, Chunyan Zheng, Junpeng Zhang, Xiaoyang Yin, Baosheng Li

Medical Oncology · 07.11.2024 · 41 (12)

DOI: 10.1007/s12032-024-02483-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 07.11.2024. Verfasst von Ling Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Southwest Medical University, Luzhou, 646000, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Esophageal Squamous Cell Carcinoma, Amino Acid Transport System y+. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Special Fund Project of the Central Government for Guiding Local Science and Technology Development of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNF-E2-Related Factor 2Esophageal Squamous Cell CarcinomaAmino Acid Transport System y+Esophageal NeoplasmsRadiation ToleranceMice, NudeHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysApoptosisSignal TransductionCell ProliferationMice, Inbred BALB CAcetamidesBenzodioxoles

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaFerroptosisML385NRF2Radiosensitivity

Substanzen

NF-E2-Related Factor 2Amino Acid Transport System y+AcetamidesBenzodioxolesSLC7A11 protein, humanNFE2L2 protein, humanML385

Autor:innen und Institutionen

  • Clinical Medical College, Southwest Medical University, Luzhou, 646000, China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, 250117, China.
  • Clinical Medical College, Southwest Medical University, Luzhou, 646000, China. bsli@sdfmu.edu.cn.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, 250117, China. bsli@sdfmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Special Fund Project of the Central Government for Guiding Local Science and Technology Development of Shandong Province

Zitieren

APA

Yan, L., Hu, H., Feng, L., Li, Z., Zheng, C., Zhang, J., Yin, X., & Li, B. (2024). ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Medical Oncology, 41(12). https://doi.org/10.1007/s12032-024-02483-6

Vancouver

Yan L, Hu H, Feng L, Li Z, Zheng C, Zhang J, et al. ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Medical Oncology. 2024;41(12). doi:10.1007/s12032-024-02483-6

BibTeX
@article{Yan2024,
  author = {Yan, Ling and Hu, Huidong and Feng, Lei and Li, Zhe and Zheng, Chunyan and Zhang, Junpeng and Yin, Xiaoyang and Li, Baosheng},
  title = {ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma},
  journal = {Medical Oncology},
  year = {2024},
  volume = {41},
  number = {12},
  doi = {10.1007/s12032-024-02483-6}
}
Kostenlos starten →